Trade

with

Pacific Biosciences of California Inc
(NASDAQ: PACB)
AdChoices
6.07
+0.41
+7.24%
After Hours :
6.07
0.00
0.00%

Open

5.79

Previous Close

5.66

Volume (Avg)

1.73M (608.41k)

Day's Range

5.76-6.27

52Wk Range

3.47-8.20

Market Cap.

428.72M

Dividend Rate ( Yield )

-

Beta

1.57

Shares Outstanding

70.63M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Biotechnology
Highlights
Analyst Recommendation: Not Available
    • Revenue

    • 28.18M

    • Net Income

    • -79.29M

    • Market Cap.

    • 428.72M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -191.16

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 1.57

    • Forward P/E

    • -

    • Price/Sales

    • 10.35

    • Price/Book Value

    • 7.26

    • Price/Cash flow

    • -14.60

      • EBITDA

      • -71.17M

      • Return on Capital %

      • -57.70

      • Return on Equity %

      • -95.02

      • Return on Assets %

      • -57.70

      • Book Value/Share

      • 0.84

      • Shares Outstanding

      • 70.63M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      -
      Not Available
        • 1 Year Price Target

        • -

        • Credit Rating

        • -

        • Analysts

        • 0

        • EPS Estimate

        • -

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 88.90

          • 40.73

          • Net Income

            YTD/YTD (last year)

          • -

          • 17.04

          • Net Income

            Q/Q (last year)

          • -

          • 98.90

          • Sales (Revenue)

            5-Year Annual Average

          • 99.09

          • 63.43

          • Net Income

            5-Year Annual Average

          • -

          • 10.65

          • Dividends

            5-Year Annual Average

          • -

          • 15.81

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 25.82

            • 82.75

            • Pre-Tax Margin

            • -191.16

            • 39.38

            • Net Profit Margin

            • -191.16

            • 31.33

            • Average Gross Margin

              5-Year Annual Average

            • 53.00

            • 82.99

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -

            • 33.42

            • Average Net Profit Margin

              5-Year Annual Average

            • -14,861.30

            • 199.05B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.23

              • 0.76

              • Current Ratio

              • 4.29

              • 2.92

              • Quick Ratio

              • 3.91

              • 2.35

              • Interest Coverage

              • -26.37

              • 38.02

              • Leverage Ratio

              • 2.17

              • 2.21

              • Book Value/Share

              • 0.84

              • 4.79

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -4.96

                • 217.39

                • P/E Ratio 5-Year High

                • -15.58

                • 634.30

                • P/E Ratio 5-Year Low

                • -0.95

                • 124.82

                • Price/Sales Ratio

                • 9.48

                • 9.52

                • Price/Book Value

                • 6.65

                • 8.61

                • Price/Cash Flow Ratio

                • -14.60

                • 50.51

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • -

                    • Dividend Date

                    • -

                    • Ex-Dividend Date

                    • -

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • -95.02

                        (-)

                      • 37.63

                        (27.20)

                      • Return on Assets %

                        (5-Year Average)

                      • -57.70

                        (-61.30)

                      • 17.22

                        (13.81)

                      • Return on Capital %

                        (5-Year Average)

                      • -77.36

                        (-)

                      • 21.78

                        (17.31)

                      • Income/Employee

                      • -

                      • 117.08k

                      • Inventory Turnover

                      • 2.98

                      • 1.48

                      • Asset Turnover

                      • 0.30

                      • 0.55

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      -77.54M
                      Operating Margin
                      -275.16
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      -14.60
                      Ownership

                      Institutional Ownership

                      61.63%

                      Top 10 Institutions

                      48.15%

                      Mutual Fund Ownership

                      14.52%

                      Float

                      74.77%

                      5% / Insider Ownership

                      3.43%

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • BlackRock Master Value Opportunities LLC

                      •  

                        2,291,956

                      • 1.03

                      • 3.25

                      • iShares Nasdaq Biotechnology

                      •  

                        913,706

                      • -0.47

                      • 1.49

                      • iShares Russell 2000 (AU)

                      •  

                        866,898

                      • -1.46

                      • 1.41

                      • Vanguard Total Stock Mkt Idx

                      •  

                        860,631

                      • 0.00

                      • 1.22

                      • BlackRock Value Opportunities V.I. Fund

                      •  

                        738,044

                      • 0.90

                      • 1.04

                      • Vanguard Extended Market Index Fund

                      •  

                        471,666

                      • 3.60

                      • 0.67

                      • iShares Russell 2000 Growth

                      •  

                        409,314

                      • 0.34

                      • 0.67

                      • Bridgeway Ultra Small Company Market

                      •  

                        222,400

                      • 0.00

                      • 0.31

                      • CREF Stock

                      •  

                        220,436

                      • -3.24

                      • 0.31

                      • Fidelity Spartan® Extended Mkt Indx Fd

                      •  

                        178,598

                      • 0.00

                      • 0.25

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Maverick Capital Ltd

                      •  

                        6,459,784

                      • 0.00%

                      • 9.15

                      • Deerfield Management Co

                      •  

                        4,695,203

                      • -13.15%

                      • 6.65

                      • Oracle Investment Management Inc

                      •  

                        3,002,508

                      • +16.57%

                      • 4.25

                      • BlackRock Advisors LLC

                      •  

                        2,943,145

                      • +10.59%

                      • 4.17

                      • Millennium Management LLC

                      •  

                        2,888,724

                      • -13.86%

                      • 4.09

                      • Blackstone Group LP

                      •  

                        2,411,556

                      • 0.00%

                      • 3.41

                      • BlackRock Fund Advisors

                      •  

                        2,247,437

                      • +2.83%

                      • 3.18

                      • Raging Capital Management LLC

                      •  

                        1,610,075

                      • +60.50%

                      • 2.28

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Biotechnology

                      Type

                      Speculative Growth

                      Style

                      Small Core

                      Pacific Biosciences of California, Inc., was incorporated in the State of Delaware in 2000. The Company develops, manufactures and markets an integrated platform for high resolution genetic analysis. It has developed a technology to ...morestudy the synthesis, composition, structure, and regulation of DNA. Combining advances in nanofabrication, biochemistry, molecular biology, surface chemistry and optics, it created a technology platform using its proprietary single molecule, real-time, or SMRT, technology. Its SMRT technology uses the natural processing power of enzymes, combined with specially designed reagents and detection systems, to record individual biochemical events as they occur. The ability to observe single molecule events in real time provides the scientific community with an advanced tool fo...morer investigating basic biochemical processes such as DNA synthesis. Its SMRT technology has the potential to advance scientific understanding by providing a window into biological processes that has not previously been open. It has commercialized the PacBioRS II High Resolution Genetic Analyzer to help scientists solve genetically complex problems. Based on its novel Single Molecule, Real-Time (SMRT) technology, its products enable scientists to increase their understanding of biological systems through targeted sequencing and insight into genetic variations. The Company's products include the SMRT Cell, Phospholinked nucleotides, the PacBio RS. Its competitors include Illumina Inc. and Thermo Fisher Scientific Inc. The names “Pacific Biosciences,” “PacBio,” “SMRT,” “SMRTbell” and its logo are the trademarks of the Company. It is subject to federal, state, local and foreign laws, regulations and permits relating to environmental, health and safety matters.lessless

                      Key People

                      Michael W. Hunkapiller

                      CEO/Chairman of the Board/Director/President

                      Susan K. Barnes

                      CFO/Executive VP

                      Brian B. Dow

                      Chief Accounting Officer/Vice President

                      Stephen M. Moore

                      Secretary/Vice President, Divisional

                      Brook H. Byers

                      Director

                      • Pacific Biosciences of California Inc

                      • 1380 Willow Road

                      • Menlo Park, CA 94025

                      • USA.Map

                      • Phone: +1 650 521-8000

                      • Fax: -

                      • pacificbiosciences.com

                      Incorporated

                      2000

                      Employees

                      318

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: